ARTICLES LIST

 

Total Results: 16203

Media ID Source Name Media Type Language Media Name Media Description Keywords Keywords Link to Article
1341 National Cancer Institute Html en Smokeless Tobacco and Cancer A fact sheet about the health risks associated with the use of smokeless tobacco.
tobacco cut size0.465919
NCI smoking cessation0.353151
safe level0.345736
oral tobacco0.470575
nicotine addiction0.363201
Human Services0.340767
Health State-of-the-Science conference0.343313
U.S. Department0.340786
tobacco-specific nitrosamines0.373338
tobacco fertilizer0.451995
advisory committee0.346137
powdered tobacco0.462627
Health Organization International0.342988
oral cancer0.332186
National Institutes0.343448
Watson C. Surveillance0.3381
Tobacco Control Monograph0.451686
moist snuff0.436686
precancerous white patches0.344838
International Agency0.339252
NCI’s Smoking0.334129
Tobacco Research0.437462
NCI fact sheet0.385333
lower lip0.34967
esophageal cancer0.332063
nicotine stays0.353085
Yes. All tobacco0.450832
National Cancer Institute0.373261
LiveHelp online chat0.341688
American snuff0.346643
polynuclear aromatic hydrocarbons0.347124
Eastern time0.340428
spitting tobacco0.470917
online text chat0.340605
polycyclic aromatic hydrocarbons0.346589
smokeless tobacco products0.615213
smokeless tobacco cause0.576883
Nicotine content0.350271
un-ionized nicotine0.348074
Surgeon General0.344959
smokeless tobacco0.995709
Yes. Smokeless tobacco0.55885
dry snuff0.363969
noncancerous oral conditions0.343638
NIH State-of-the-Science Panel0.338818
tobacco cause cancer0.483342
smoking cessation counselor0.38611
tobacco juices0.469352
harmful chemicals0.350583
CLICK HERE
1388 National Cancer Institute Html en Neuroblastoma Treatment (PDQ®)–Health Professional Version Expert-reviewed information summary about the treatment of childhood neuroblastoma.
neuroblastoma0.976116
childhood cancer neuroblastoma0.551793
major familial neuroblastoma0.521543
neuroblastoma progression0.496843
unresectable/disseminated neuroblastoma0.495818
Neuroblastoma Study Group0.537536
intermediate-risk neuroblastoma patients0.580486
neuroblastoma molecular diagnostics0.511987
hereditary neuroblastoma0.561905
intermediate-risk neuroblastoma group0.584332
low-risk neuroblastoma susceptibility0.521417
neuroblastoma identifies chromothripsis0.508284
neuroblastoma risk group0.724371
low-risk neuroblastoma0.617352
High-risk neuroblastoma tumors0.54129
high-risk neuroblastoma0.745428
neuroblastoma section0.536455
neuroblastoma SNP association0.525331
stage IV-S neuroblastoma0.494981
neuroblastoma cell0.546055
Neuroblastoma Pathology Committee0.5037
et al.0.867573
Neuroblastoma Pathology Classification0.578039
neuroblastoma tumors0.563844
stage iv neuroblastoma0.527215
diagnostic neuroblastoma samples.0.552115
international neuroblastoma0.731336
international neuroblastoma staging0.561855
neuroblastoma cases0.533897
PUBMED Abstract0.580731
multifocal neuroblastoma0.525099
neuroblastoma cells0.534711
aggressive MYC-driven neuroblastoma0.504084
Pediatr Blood Cancer0.580995
Oncology Group study0.606704
Italian Neuroblastoma group0.510786
international neuroblastoma risk0.640282
high-risk neuroblastoma group0.601822
intermediate-risk neuroblastoma0.586941
International Neuroblastoma Pathology0.642606
childhood neuroblastoma0.512977
Abstract0.706617
Clin Oncol0.827663
low-risk neuroblastoma group0.586425
Neuroblastoma Susceptibility Locus0.517512
heterogeneous MYCN-amplified neuroblastoma0.505216
neuroblastoma oncogene0.499459
metastatic neuroblastoma0.519613
oncology group0.651154
CLICK HERE
1524 National Cancer Institute Html en Endometrial Cancer Treatment (PDQ®)–Patient Version Expert-reviewed information summary about the treatment of endometrial cancer.
cancer treatment0.541916
Lymph node dissection0.478324
metastatic endometrial cancer0.510561
body0.511838
PDQ cancer information0.531329
clinical trial search0.465384
uterus0.585793
endometrial cancer spreads0.509404
mTOR inhibitors0.464666
clinical trials0.736061
cancer information summary0.508345
clinical trial0.5843
Low-risk endometrial cancer0.501844
breast cancer patients0.483969
patients0.494506
NCI PDQ cancer0.479485
malignant tumor cells0.467809
lymph nodes0.52827
endometrial hyperplasia0.468477
radiation therapy0.605187
Treatment Editorial Board0.469208
endometrial cancer0.889926
radical hysterectomy0.471844
treatment0.622425
cancer prevention0.463817
new cancer treatments0.470535
NCI-supported cancer0.463476
cancer cells0.753566
Cancer Information Service0.471559
specific cancer cells0.479989
treatment clinical trials0.48357
High-risk endometrial cancer0.500552
endometrial tissue0.464689
National Cancer Institute0.508844
new treatment0.504217
cervix0.474629
external radiation therapy0.482834
non-polyposis colon cancer0.477796
tissue samples0.463584
cancer research process0.465542
cancer clinical trials0.501833
stage0.522219
Endometrial Cancer Treatment0.516218
Recurrent endometrial cancer0.629078
fallopian tubes0.494755
cancer information summaries0.469865
treatment options0.466033
comprehensive cancer information0.469896
internal radiation therapy0.504839
CLICK HERE
1636 National Cancer Institute Html en Cartilage (Bovine and Shark) (PDQ®)–Patient Version Expert-reviewed information summary about the use of bovine and shark cartilage as a treatment for people with cancer. Note: The information in this summary is no longer being updated and is provided for reference purposes only.
cancer treatment0.483107
human cancer cells0.399726
cartilage treatment0.54785
shark cartilage0.911115
PDQ cancer information0.489648
Cancer Complementary0.397259
lung cancer0.396037
new blood vessels0.529873
blood vessel growth0.688109
clinical trials0.661965
testing bovine cartilage0.553086
powdered cartilage products0.528871
bovine cartilage0.754583
cancer information summary0.450971
clinical trial0.545778
patients0.414137
randomized clinical trial0.405563
NCI PDQ cancer0.409125
cancer information database0.395004
liquid shark cartilage0.530016
liquid cartilage products0.569642
powdered shark cartilage0.613657
cancer information0.501779
breast cancer cells0.394321
shark cartilage products0.633195
laboratory study0.408409
cartilage products0.782377
Complementary Therapies Editorial0.405419
cancer cells0.530307
Cancer Information Service0.450397
preclinical studies0.47111
cartilage product AE–941/Neovastat0.510074
dietary supplements0.394341
National Cancer Institute0.540172
studies0.47228
alternative medicine0.440784
pancreatic cancer cells0.3965
human cartilage0.495387
PDQ Cartilage0.50056
shark cartilage product0.665863
cartilage0.96677
animal studies0.448189
standard cancer treatment0.405448
alternative therapies0.399716
cancer information summaries0.395389
powdered cartilage0.59313
bovine cartilage product0.523261
cancer0.811115
CLICK HERE
1918 National Cancer Institute Html es Tratamiento del cáncer de vías biliares (colangiocarcinoma) (PDQ®)–Versión para pacientes Resumen de información revisada por expertos acerca del tratamiento del cáncer de vías biliares.
pequeñas incisiones0.429743
siguientes procedimientos0.496942
pequeño número0.430642
estadio iv0.806715
IIIB.Estadio IIIA0.428895
siguientes afecciones0.443112
siguientes tipos0.469726
múltiples tumores0.426811
rayos x0.429804
estadio ivb0.620663
llama estadificación0.509816
vías extrahepáticas distal0.500664
rama derecha0.425053
biliares extrahepáticas distal0.562053
estadio iva0.611281
quimioterapia sistémica0.540152
National Cancer Institute0.425091
quimioterapia sistémica ayuda0.448855
colangiocarcinomas.ampliar anatomía0.433411
estadios iiia0.428062
siguientes riesgos0.418955
estadio iib.estadio iia0.483131
Instituto Nacional0.443118
PDQ Tratamiento0.452416
siguientes grupos0.435798
vías biliares.Cáncer0.522502
Colangiopancreatografía retrógrada0.432583
marcador tumoral ca0.457024
color arcilla0.428813
fosfatasa alcalina0.43337
siguientes factores0.436523
partes distantes0.435203
Physician Data Query0.487514
estadio ib.estadio ia0.481572
estadio iii0.699586
antígeno carcinoembrionario0.500245
biliar extrahepático distal0.995606
medicamentos radiosensibilizadores0.497933
pequeños conductos0.46338
estadio ivb.estadio iva0.489932
CLICK HERE
1927 National Cancer Institute Html es Tratamiento del linfoma de Hodgkin infantil (PDQ®)–Versión para pacientes Resumen de información revisada por expertos acerca del tratamiento del linfoma de Hodgkin infantil.
siguientes procedimientos0.539535
células madre0.949818
estadio iv0.500925
adultos jóvenes0.452563
órgano cercano.ampliar linfoma0.561365
siguientes elementos0.448931
sudores nocturnos0.484622
faja ajustadora0.430459
siguientes especialistas0.43177
siguientes tipos0.443725
vía oral0.419326
rayos x0.473568
Hodgkin Lymphoma0.582459
abdomen).ampliar linfoma0.535694
detecte.ampliar exploración0.434601
enlace drugs approved0.498183
escáner tep0.492453
niño ayuda0.424524
estadio iiies0.760474
riesgo intermedio0.462626
efectos tardíos0.664689
estadio ie0.575058
células anormales.ampliar aspiración0.485872
PDQ Efectos tardíos0.461638
National Cancer Institute0.420283
sustancia quizás0.427861
siguientes lugares0.433237
siguientes riesgos0.418851
Instituto Nacional0.434896
PDQ Tratamiento0.682769
estadio iie0.500587
Hodgkin recién0.557678
explorador tep0.443167
estadio e0.45134
nuevos tipos0.421275
Physician Data Query0.471298
posibles efectos0.420063
infancia quizás0.428464
estadio iiis0.959473
ósea fabrica glóbulos0.493208
pelvis.ampliar imágenes0.420331
distinta intensidad0.419212
almacena células0.485736
siguientes pruebas0.485604
siguientes estadios0.440037
CLICK HERE
1933 National Cancer Institute Html es Tratamiento del cáncer de seno (mama) en el embarazo (PDQ®)–Versión para pacientes Resumen de información revisada por expertos acerca del tratamiento de cáncer de seno (mama) en el embarazo.
estadio lllC0.545921
procedimientos quizás0.519027
estadio iv0.622294
siguientes aspectos0.528664
secciones llamadas lóbulos0.542754
estadio lllB0.547235
estadio lllA0.548629
estadios ia0.51696
ganglio linfático centinela0.983407
Oncotype DX0.522717
rayos x0.518956
estadio ib0.594193
prueba ayuda0.551927
estadio ia0.593122
pezón afección0.529911
enlace drugs approved0.522117
mama.ampliar cirugía0.515861
causó hinchazón0.517244
National Cancer Institute0.51629
cuántos genes0.520169
siguientes riesgos0.513473
realidad células0.541214
Instituto Nacional0.528985
cuáles lesiones0.51826
estadio iiia0.547361
PDQ Tratamiento0.523188
estadio iiic0.745067
cáncer.ampliar mamografía0.525478
estadio iia0.550898
estadio llB0.548944
estadio llA0.550289
cuánta proteína0.522295
siguientes casos0.520535
Physician Data Query0.558856
carcinoma lobulillar0.602006
siguientes partes0.548502
Breast Cancer0.511799
mamas.ampliar carcinoma lobulillar0.536157
siguientes pruebas0.564002
vasos sanguíneos0.630183
CLICK HERE
1959 National Cancer Institute Html es Tratamiento del cáncer de vagina (PDQ®)–Versión para pacientes Resumen de información revisada por expertos acerca del tratamiento del cáncer de vagina.
parto).ampliar anatomía0.303951
siguientes procedimientos0.324612
siguientes aspectos0.303939
pequeña cantidad0.302401
estadio ii0.3299
vía oral0.301938
historial médico0.303531
rayos x0.302933
estadio ivb0.318379
intensa luz0.302127
Pap.Ampliar Prueba0.303248
estadio iva0.313191
National Cancer Institute0.301226
realidad células0.307398
vagina causa efectos0.315579
sangrado anormal0.312233
áreas anormales.ampliar examen0.305435
Instituto Nacional0.302424
PDQ Tratamiento0.308282
presente sección0.301728
Physician Data Query0.305028
medicamento des0.324421
prueba pap0.303798
estadio iii0.307024
pequeña incisión0.302169
cuello uterino0.962189
histerectomía abdominal0.303006
procedimiento.ampliar ureteroscopía0.30314
siguientes estadios0.303001
CLICK HERE
2078 National Cancer Institute Html es Tomografía computarizada (TC) y exploraciones para cáncer Hoja informativa sobre el procedimiento y tecnología de la TC y sus usos para examen de detección, diagnóstico y tratamiento del cáncer. Hoja informativa 5.2s del Instituto Nacional del Cáncer.
imágenes llamada fdg0.212869
hallazgos anómalos0.149049
Pediatric Computed Tomography0.196499
persona promedio0.156787
Retrieved July0.224181
rayos x0.774234
from ct scans0.197405
ACR Appropriateness Criteria®0.187415
Patient Safety0.146744
Low Levels0.215439
Radiation Risks from0.30681
radiation dose0.305638
health care providers0.311726
Lung Screening Trial0.175719
risks from0.542401
Assess Health Risks0.201898
Retrieved June0.147049
Exposición Innecesaria0.154118
Internal Medicine0.215735
Estados Unidos0.457591
PubMed Abstract0.688591
from ct0.241742
mejores imágenes0.190153
Cancer Imaging Program0.180886
SEER Cancer Statistics0.179794
Reducing Radiation from0.255009
New Hampshire Avenue0.163654
radiation risks0.481539
alto riesgo0.166125
Drug Administration0.216737
British Medical Journal0.160951
retrospective cohort study0.171194
Mi Historia Médica0.162596
lifetime attributable risk0.182458
American College0.194044
National Cancer Institute0.177442
Health Risks from0.371263
baja dosis0.918737
dosis anual promedio0.421854
from diagnostic imaging0.192917
arteriopatía coronaria0.148972
computed tomography0.455191
Ionizing Radiation0.294632
risks from exposure0.389205
National Research Council0.163031
pequeños riesgos0.152571
Colegio Americano0.296344
Estudio Nacional0.328775
Sociedad Radiológica0.211562
CLICK HERE
16256 National Cancer Institute Html en Áreas de investigación Sostener un progreso contra el cáncer requiere que se avance a través del continuo de investigación. Entérese de lo extenso que es el trabajo del NCI y de los programas que apoya el instituto para hacer avanzar la investigación oncológica.
National Cancer Institute0.966549
CLICK HERE

 

 

 

Terms of Use | Privacy Policy
©2017 ARCHES Technology. All Rights Reserved.